134 related articles for article (PubMed ID: 36606302)
21. Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients.
Waddle MR; Sio TT; Van Houten HK; Foote RL; Keole SR; Schild SE; Laack N; Daniels TB; Crown W; Shah ND; Miller RC
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1078-1082. PubMed ID: 28939229
[TBL] [Abstract][Full Text] [Related]
22. Radiation oncology in Australia: workforce, workloads and equipment 1986-1999.
Wigg DR; Morgan GW
Australas Radiol; 2001 May; 45(2):146-69. PubMed ID: 11380358
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy in prostate cancer treatment: results of the patterns of care study in Korea.
Chang AR; Park W
Radiat Oncol J; 2017 Mar; 35(1):25-31. PubMed ID: 28292006
[TBL] [Abstract][Full Text] [Related]
24. Brachytherapy in Belgium in 2018. A national survey of the brachytherapy study group of the Belgian SocieTy for Radiotherapy and Oncology (BeSTRO).
Salembier C; De Hertogh O; Daisne JF; Palumbo S; Van Gestel D
Radiother Oncol; 2020 Sep; 150():245-252. PubMed ID: 32679309
[TBL] [Abstract][Full Text] [Related]
25. The changes of radiotherapy in Lithuania: infrastructure, utilization rate, and cost.
Mineikytė R; Janulionis E; Atkočius V; Jaruševičius L; Plieskienė A; Gečas J
Acta Med Litu; 2016; 23(1):17-23. PubMed ID: 28356788
[No Abstract] [Full Text] [Related]
26. Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources.
Esco R; Palacios A; Pardo J; Biete A; Carceller JA; Veiras C; Vazquez G;
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):319-27. PubMed ID: 12738304
[TBL] [Abstract][Full Text] [Related]
27. Access to Radiation Therapy: From Local to Global and Equality to Equity.
Laskar SG; Sinha S; Krishnatry R; Grau C; Mehta M; Agarwal JP
JCO Glob Oncol; 2022 Aug; 8():e2100358. PubMed ID: 35960905
[TBL] [Abstract][Full Text] [Related]
28. Status of Government-Funded Radiotherapy Services in Nigeria.
Aruah SC; Chidebe RCW; Orjiakor TC; Uba F; Shagaya UN; Ugwanyi C; Umar AA; Ige T; Asogwa OC; Ahmadu OT; Ali-Gombe M; Adewumi A; Okwor VC; Mutiu JA; Bello B; Eriba LO; Ahmed YA; Bisalla A; Itanyi U; Balogun RA; Alabi S; Pistenmaa D; Coleman CN; Manjit D
JCO Glob Oncol; 2023 Jun; 9():e2200406. PubMed ID: 37348033
[TBL] [Abstract][Full Text] [Related]
29. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
[TBL] [Abstract][Full Text] [Related]
30. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
31. Risk of second cancers according to radiation therapy technique and modality in prostate cancer survivors.
Berrington de Gonzalez A; Wong J; Kleinerman R; Kim C; Morton L; Bekelman JE
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):295-302. PubMed ID: 25636756
[TBL] [Abstract][Full Text] [Related]
32. Estimation of the medical need for carbon-ion radiotherapy in Korea.
Cho I; Seo YS; Jung W; Kim MS
J Radiat Res; 2018 Sep; 59(5):588-592. PubMed ID: 29939311
[TBL] [Abstract][Full Text] [Related]
33. [Report on current status of Hungarian radiotherapy].
Major T; Király R; Polgár C
Magy Onkol; 2019 Jun; 63(2):93-101. PubMed ID: 31225532
[TBL] [Abstract][Full Text] [Related]
34. Recent trends in intensity-modulated radiation therapy use in Korea.
Huh SJ; Park W; Choi DH
Radiat Oncol J; 2019 Dec; 37(4):249-253. PubMed ID: 31918461
[TBL] [Abstract][Full Text] [Related]
35. Patterns of radiotherapy infrastructure in Japan and in other countries with well-developed radiotherapy infrastructures.
Nakamura K; Konishi K; Komatsu T; Sasaki T; Shikama N
Jpn J Clin Oncol; 2018 May; 48(5):476-479. PubMed ID: 29635375
[TBL] [Abstract][Full Text] [Related]
36. Emerging Use of Public-Private Partnerships in Public Radiotherapy Facilities in Nigeria.
Anakwenze Akinfenwa CP; Ibraheem A; Nwankwo K; Lasebikan N; Ali-Gombe M; Aliyu UM; Ikhile E; Adegboyega O; Abdullahi A; Klopp AH; Schmeler K; Lin LL; Jhingran A; Page BR; Leng J; Grover S; Ntekim A
JCO Glob Oncol; 2021 Aug; 7():1260-1269. PubMed ID: 34351813
[TBL] [Abstract][Full Text] [Related]
37. A systematic review of radiotherapy capacity in low- and middle-income countries.
Grover S; Xu MJ; Yeager A; Rosman L; Groen RS; Chackungal S; Rodin D; Mangaali M; Nurkic S; Fernandes A; Lin LL; Thomas G; Tergas AI
Front Oncol; 2014; 4():380. PubMed ID: 25657930
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy infrastructure and human resources in Europe - present status and its implications for 2020.
Datta NR; Samiei M; Bodis S
Eur J Cancer; 2014 Oct; 50(15):2735-43. PubMed ID: 25085229
[TBL] [Abstract][Full Text] [Related]
39. Determining the need and utilization of radiotherapy in cancers of the breast, cervix, lung, prostate and rectum: A population level study.
Shack L; Lu S; Weeks LA; Craighead P; Kerba M
Radiother Oncol; 2017 Jan; 122(1):152-158. PubMed ID: 28012795
[TBL] [Abstract][Full Text] [Related]
40. Practice patterns for prostate cancer in nine central and northern Italy radiation oncology centers: a survey including 1759 patients treated during two decades (1980-1998).
Magrini SM; Bertoni F; Vavassori V; Villa S; Cagna E; Maranzano E; Pertici M; Pradella R; Spediacci MA; Chiavacci A; Ambrosi E; Livi L; Magli A; Bellavita R; Bossi A; Biti G
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1310-9. PubMed ID: 11955744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
